August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
James Gulley: First-in-class bispecific antibody that targets TCR Vbeta chain
Nov 12, 2024, 13:44

James Gulley: First-in-class bispecific antibody that targets TCR Vbeta chain

James L. Gulley, Director of the Medical Oncology Service at National Cancer Institute, shared a post on X:

I am delighted to give you the SITC 2024 presentation details of the first-in-human, international study of this first-in-class bispecific antibody that targets TCR Vbeta chain and brings with it IL-2.”

James Gulley: First-in-class bispecific antibody that targets TCR Vbeta chain